• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral
    |
    Weekly News Recap #Phispers
    J&J’s 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump’s voucher program

    J&J’s 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump’s voucher program

    In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

    Impressions : 1746

    Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

    Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

    As we return from our one-week break due to the CPhI Worldwide, we find our double-dose Phispers edition to be filled with se...

    Impressions : 1451

    Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo’s Rybelsus to reduce heart risk in diabetics

    Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo’s Rybelsus to reduce heart risk in diabetics

    In this week’s Phispers, China’s Innovent Biologics signed one of the largest cross-border biotech deals in Asia. U...

    Impressions : 1558

    Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

    Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

    In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...

    Impressions : 1328

    Lundbeck acquires Longboard for US$ 2.6 billion; Roche’s Itovebi bags FDA nod for breast cancer

    Lundbeck acquires Longboard for US$ 2.6 billion; Roche’s Itovebi bags FDA nod for breast cancer

    This week’s is a double dose Phispers, as we return from a one-week break due to CPhI Worldwide. The fortnight saw severa...

    Impressions : 1452

    BMS med wins landmark FDA nod for schizophrenia; Sanofi’s Dupixent approved to treat COPD

    BMS med wins landmark FDA nod for schizophrenia; Sanofi’s Dupixent approved to treat COPD

    In this week’s Phispers, the US Food and Drug Administration (FDA) approved Bristol Myers Squibb’s groundbreaking s...

    Impressions : 1386

    Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn

    Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn

    It was a week of drug approvals, as the US Food and Drug Administration (FDA) okayed several therapies before the close of the...

    Impressions : 3038

    Lilly to launch Zepbound in more markets this year; Casgevy bags second FDA nod

    Lilly to launch Zepbound in more markets this year; Casgevy bags second FDA nod

    This week’s Phispers brings you news from the annual World Economic Forum in Davos (Switzerland) where some senior execut...

    Impressions : 2123

    J&J to spin off consumer biz within two years; Biden nominates Califf as FDA chief

    After a gap of a week, Phispers is back with reports of some big developments in the world of pharmaceuticals. The biggest news...

    Impressions : 1853

    Chinese prices of APIs increase dramatically; former Operation Warp Speed head accused of sexual harassment

    This week, Phispers has more updates on the AstraZeneca-Oxford vaccine which continues to be mired in controversies. Earlier th...

    Impressions : 3108

    Sanofi overhauls executive committee; FDA recalls metformin due to unacceptable levels of NDMA impurity

    This week, Phispers brings news on various developments across the world as a result of the Covid-19 pandemic. While US Presi...

    Impressions : 89389

    US rolls out Operation Warp Speed, announces US$ 354 million manufacturing contract for essential medicines

    This week, Phispers brings you lots of updates on vaccine development, news and rhetoric emerging out of the ongoing Covid-19 p...

    Impressions : 152110

    ‘FDA compromised standards to get Bayer’s chloroquine’; HCQ study shows no benefits, higher deaths in study

    This week, Phispers brings you updates on remdesivir, hydroxychloroquine (HCQ) and chloroquine — drugs being touted as tr...

    Impressions : 3930

    India partially lifts Hydroxychloroquine, Paracetamol export ban; delays by FTC lead to nixing of US$ 1 billion Sandoz deal

    This week, Phispers has more updates on the deadly novel coronavirus. The US, which has reported over 400,000 cases of Covid-...

    Impressions : 2303

    US plans to reduce drug manufacturing dependence on China, India; Cross-contamination problems at Cipla

    This week, Phispers has more updates on Covid-19. The US is preparing an executive order that will reduce the country’s...

    Impressions : 2094

    Covid-19 update: Indian firms airlift APIs from China; FDA suspends foreign inspections; pharma events get cancelled

    This week, Phispers brings you more updates on the novel coronavirus, as the WHO declared its spread a pandemic. The USFDA ha...

    Impressions : 6942

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.